                               SEQUENCE LISTING

<110> IBC PHARMACEUTICALS, INC.
 
<120> PEGYLATION BY THE DOCK AND LOCK (DNL) TECHNIQUE

<130> IBC118W03

<140>
<141> 

<150> 11/925,408
<151> 2007-10-26

<160> 33    

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 1
Cys Gly Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile 
1               5                   10                  15      


Gln Gln Ala Gly Cys 
            20      


<210> 2
<211> 63
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 2
Lys Ser His His His His His His Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Cys Gly His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu 
            20                  25                  30          


Gln Gly Tyr Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val 
        35                  40                  45              


Glu Phe Ala Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
    50                  55                  60              


<210> 3
<211> 45
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 3
tctagacaca ggacctcatc atggccttga cctttgcttt actgg                     45


<210> 4
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
ggatccatga tggtgatgat ggtgtgactt ttccttactt cttaaacttt cttgc          55


<210> 5
<211> 41
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 5
tctagacaca ggacctcatc atggctggac ctgccaccca g                         41


<210> 6
<211> 51
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 6
ggatccatga tggtgatgat ggtgtgactt gggctgggca aggtggcgta g              51


<210> 7
<211> 40
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 7
tctagacaca ggacctcatc atgggggtgc acgaatgtcc                           40


<210> 8
<211> 49
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 8
ggatccatga tggtgatgat ggtgtgactt tctgtcccct gtcctgcag                 49


<210> 9
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<220>
<221> MOD_RES
<222> (1)..(1)
<223> Cys(S-tBu)

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Cys(S-tBu)

<400> 9
Cys Gly Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile 
1               5                   10                  15      


Gln Gln Ala Gly Cys Gly 
            20          


<210> 10
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 10
Ser His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly Tyr 
1               5                   10                  15      


Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val Glu Phe Ala 
            20                  25                  30          


Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
        35                  40                  


<210> 11
<211> 45
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 11
Cys Gly His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly 
1               5                   10                  15      


Tyr Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val Glu Phe 
            20                  25                  30          


Ala Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
        35                  40                  45  


<210> 12
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 12
Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile Gln Gln 
1               5                   10                  15      


Ala 
    


<210> 13
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 13
gaacctcgcg gacagttaag                                                 20


<210> 14
<211> 53
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 14
ggatcctccg ccgccgcagc tcttaggttt cttgtccacc ttggtgttgc tgg            53


<210> 15
<211> 55
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 15
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser His Ile Gln Ile 
1               5                   10                  15      


Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly Tyr Thr Val Glu Val Leu 
            20                  25                  30          


Arg Gln Gln Pro Pro Asp Leu Val Glu Phe Ala Val Glu Tyr Phe Thr 
        35                  40                  45              


Arg Leu Arg Glu Ala Arg Ala 
    50                  55  


<210> 16
<211> 92
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 16
gtggcgggtc tggcggaggt ggcagccaca tccagatccc gccggggctc acggagctgc     60

tgcagggcta cacggtggag gtgctgcgac ag                                   92


<210> 17
<211> 92
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 17
gcgcgagctt ctctcaggcg ggtgaagtac tccactgcga attcgacgag gtcaggcggc     60

tgctgtcgca gcacctccac cgtgtagccc tg                                   92


<210> 18
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 18
ggatccggag gtggcgggtc tggcggaggt                                      30


<210> 19
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 19
cggccgtcaa gcgcgagctt ctctcaggcg                                      30


<210> 20
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 20
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ile Glu Tyr 
1               5                   10                  15      


Leu Ala Lys Gln Ile Val Asp Asn Ala Ile Gln Gln Ala 
            20                  25                  


<210> 21
<211> 96
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 21
ggatccggag gtggcgggtc tggcggaggt ggcagccaga tcgagtacct ggccaagcag     60

atcgtggaca acgccatcca gcaggcctga cggccg                               96


<210> 22
<211> 96
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 22
cggccgtcag gcctgctgga tggcgttgtc cacgatctgc ttggccaggt actcgatctg     60

gctgccacct ccgccagacc cgccacctcc ggatcc                               96


<210> 23
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 23
ggatccggag gtggcgggtc tggcggaggt                                      30


<210> 24
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 24
cggccgtcag gcctgctgga tg                                              22


<210> 25
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 25
Gly Gly Gly Gly Ser Gly Gly Gly Cys Gly 
1               5                   10  


<210> 26
<211> 73
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 26
gatccggagg tggcgggtct ggcggaggtt gcggccacat ccagatcccg ccggggctca     60

cggagctgct gca                                                        73


<210> 27
<211> 65
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 27
gcagctccgt gagccccggc gggatctgga tgtggccgca acctccgcca gacccgccac     60

ctccg                                                                 65


<210> 28
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 28
agatctggcg cacctgaact cctg                                            24


<210> 29
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      oligonucleotide

<400> 29
gaattcggat cctttacccg gagacaggga gag                                  33


<210> 30
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Cys(SS-tBu)

<400> 30
Cys Gly Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile 
1               5                   10                  15      


Gln Gln Ala Gly Cys 
            20      


<210> 31
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Cys(SS-tBu)

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Gly-EDANS

<400> 31
Cys Gly Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile 
1               5                   10                  15      


Gln Gln Ala Gly Cys Gly 
            20          


<210> 32
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      6xHis tag

<400> 32
His His His His His His 
1               5       


<210> 33
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide

<400> 33
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser 
1               5                   10  


